Almost four million doses of the AstraZeneca/Oxford COVID-19 vaccine has arrived Nigeria. The vaccines were shipped via the COVAX Facility. This COVAX facility is a partnership between CEPI, Gavi, UNICEF and WHO. The first batch of the vaccine landed around noon at the Nnamdi Azikwe International Airport. The AstraZeneca/Oxford vaccine is manufactured by the Serum Institute of India, from Mumbai to Abuja. In a statement, the United Nations in Nigeria said the arrival marked a historic step towards the goal to ensure equitable distribution of COVID-19 vaccines globally. “This is a landmark moment for the country and the COVAX Facility’s mission to help end the acute phase of the pandemic by enabling equitable access to these vaccines across the world. We are glad to see Nigeria is amongst the first receiving the doses from COVAX, thanks to the excellent level of preparedness put in place by the Government of Nigeria,” said Thabani Maphosa, Managing Director for Country Programmes at Gavi, the Vaccine Alliance.